Pure Global

Adenovirus IgM CLIA Microparticles - India CDSCO Medical Device Registration

Adenovirus IgM CLIA Microparticles is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000395_f7d6f8e6ed349d64a2b8a02e42e6f8f1_7fe3cd80cf9b85df79d743024a473723. This device is marketed under the brand name T4 CLIA Microparticles. The license holder is Matrix Labs, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Adenovirus IgM CLIA Microparticles
UID: IMP/IVD/2019/000395_f7d6f8e6ed349d64a2b8a02e42e6f8f1_7fe3cd80cf9b85df79d743024a473723

Brand Name

T4 CLIA Microparticles

License Holder

Matrix Labs

Device Class

Class B

Approving Authority

CDSCO

Product Information

This assay is based on a chemiluminescent microparticle immunoassay (T4 CLIA Microparticles) for the qualitative determination of Adenovirus IgM (T4 CLIA Microparticles) in human serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing